ASGCT Supports Biomedical Research Act

ASGCT has joined more than two dozen other organizations in signing on to support the National Biomedical Research Act (S. 2212). This bill would provide a new funding stream of $5 billion annually for ten years to a Biomedical Research Fund to be distributed to the NIH and FDA, supplementing existing appropriations.

The funding would be targeted to select research categories, including “disruptive innovation”—breakthrough research on diseases with unmet medical needs or for which current treatments are inadequate. Other focus areas relevant to ASGCT’s priorities include basic research, research by early career scientists, regulatory science, and the development of new medical products.

Sen. Elizabeth Warren introduced the legislation, along with 15 original co-sponsors, as a way to restore some of the NIH funding cuts that occurred for over a decade. The bill would bring the NIH budget back to approximately 2006 levels, adjusted for inflation.

Related Articles